Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Demerol — DEMEROL
Application NDA005010 (NDA)
Demerol — DEMEROL
Application NDA021171 (NDA)
Hiprex — UREX
Application NDA016151 (NDA)
Hiprex — HIPREX
Application NDA017681 (NDA)
Eldepryl — SELEGILINE HYDROCHLORIDE
Application NDA019334 (NDA)
Eldepryl — ELDEPRYL
Application NDA020647 (NDA)
Eldepryl — ZELAPAR
Application NDA021479 (NDA)
Eldepryl — EMSAM
Application NDA021336 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)